FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ronald Boshuizen

Research Profile

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Molecular Sequence Data

Anatomy

Living Beings

Disorders

Prion Diseases

Physiology

Cell Survival

Co-author Network

Publications

TOP 3
Ronald S Boshuizen; Michela Morbin; Giulia Mazzoleni; Fabrizio Tagliavini; Rob H Meloen; Johannes P M Langedijk
Polyanion induced fibril growth enables the development of a reproducible assay in solution for the screening of fibril interfering compounds, and the investigation of the prion nucleation site.
Rona Wilson; Clive Bate; Ronald S Boshuizen; Alun Williams; James Brewer
Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide.
Johannes P M Langedijk; gloria fuentes; Ronald S Boshuizen; Alexandre Bonvin
Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ronald Boshuizen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Ronald S Boshuizen; Michela Morbin; Giulia Mazzoleni; Fabrizio Tagliavini; Rob H Meloen; Johannes P M Langedijk
Polyanion induced fibril growth enables the development of a reproducible assay in solution for the screening of fibril interfering compounds, and the investigation of the prion nucleation site.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2007;14(3):205-19.
2007: Rona Wilson; Clive Bate; Ronald S Boshuizen; Alun Williams; James Brewer
Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide.
BMC neuroscience 2007;8():99.
2006: Johannes P M Langedijk; gloria fuentes; Ronald S Boshuizen; Alexandre Bonvin
Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies.
Journal of molecular biology 2006;360(4):907-20.
2006: Atoosa Familian; Ronald S Boshuizen; Piet Eikelenboom; Robert Veerhuis
Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation.
Glia 2006;53(3):233-40.
2005: Clive Bate; Ronald S Boshuizen; Alun Williams
Microglial cells kill prion-damaged neurons in vitro by a CD14-dependent process.
Journal of neuroimmunology 2005;170(1-2):62-70.
2005: Robert Veerhuis; Ronald S Boshuizen; Atoosa Familian
Amyloid associated proteins in Alzheimer's and prion disease.
Current drug targets. CNS and neurological disorders 2005;4(3):235-48.
2005: Robert Veerhuis; Ronald S Boshuizen; Michela Morbin; Giulia Mazzoleni; Jeroen J M Hoozemans; Johannes P M Langedijk; Fabrizio Tagliavini; Jan P M Langeveld; Piet Eikelenboom
Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q.
Neurobiology of disease 2005;19(1-2):273-82.
2004: Ronald S Boshuizen; Jan P M Langeveld; Mario Salmona; Alun Williams; Rob H Meloen; Johannes P M Langedijk
An in vitro screening assay based on synthetic prion protein peptides for identification of fibril-interfering compounds.
Analytical biochemistry 2004;333(2):372-80.
2002: Clive Bate; Ronald S Boshuizen; Jan P M Langeveld; Alun Williams
Temporal and spatial relationship between the death of PrP-damaged neurones and microglial activation.
Neuroreport 2002;13(13):1695-700.
2002: Robert Veerhuis; Jeroen J M Hoozemans; Ingrid Janssen; Ronald S Boshuizen; Jan P M Langeveld; Piet Eikelenboom
Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
Brain research 2002;925(2):195-203.
2001: NJ Beekman; Wim M M Schaaper; Jan P M Langeveld; Ronald S Boshuizen; Rob H Meloen
The nature of the bond between peptide and carrier molecule determines the immunogenicity of the construct.
The journal of peptide research : official journal of the American Peptide Society 2001;58(3):237-45.
2001: Jan P M Langeveld; Frank R Brennan; Jorge Luis Martínez-Torrecuadrada; Tim D Jones; Ronald S Boshuizen; Carmen Vela; J Ignacio Casal; Søren Kamstrup; K Dalsgaard; Rob H Meloen; M M Bendig; W D O Hamilton
Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus.
Vaccine 2001;19(27):3661-70.
2001: Jan P M Langeveld; J Martinez-Torrecuadrada; Ronald S Boshuizen; Rob H Meloen; J Ignacio Casal
Characterisation of a protective linear B cell epitope against feline parvoviruses.
Vaccine 2001;19(17-19):2352-60.
1998: Søren Kamstrup; Jan P M Langeveld; Anette Bøtner; J Nielsen; Wim M M Schaaper; Ronald S Boshuizen; J Ignacio Casal; P Højrup; Carmen Vela; Rob H Meloen; K Dalsgaard
Mapping the antigenic structure of porcine parvovirus at the level of peptides.
Virus research 1998;53(2):163-73.
1997: NJ Beekman; Wim M M Schaaper; G I Tesser; K Dalsgaard; Søren Kamstrup; Jan P M Langeveld; Ronald S Boshuizen; Rob H Meloen
Synthetic peptide vaccines: palmitoylation of peptide antigens by a thioester bond increases immunogenicity.
The journal of peptide research : official journal of the American Peptide Society 1997;50(5):357-64.
1997: K Dalsgaard; A Uttenthal; Tim D Jones; F Xu; A Merryweather; W D O Hamilton; Jan P M Langeveld; Ronald S Boshuizen; Søren Kamstrup; George P Lomonossoff; C Porta; Carmen Vela; J Ignacio Casal; Rob H Meloen; P B Rodgers
Plant-derived vaccine protects target animals against a viral disease.
Nature biotechnology 1997;15(3):248-52.
1994: Jan P M Langeveld; J Ignacio Casal; E Cortés; G van de Wetering; Ronald S Boshuizen; Wim M M Schaaper; K Dalsgaard; Rob H Meloen
Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide.
Vaccine 1994;12(15):1473-80.